Status:
COMPLETED
Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
Lead Sponsor:
Hospital Authority, Hong Kong
Collaborating Sponsors:
The University of Hong Kong
Conditions:
Glomerulonephritis, Membranous
Glomerulosclerosis, Focal
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This is a prospective randomized open-label pilot study to investigate the effect of mycophenolate mofetil treatment in patients with abnormal urine protein excretion due to membranous nephropathy (MN...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- abnormal urine protein excretion and biopsy-proven idiopathic membranous nephropathy or focal segmental glomerulosclerosis
Exclusion
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2006
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00404833
Start Date
January 1 2003
End Date
December 1 2006
Last Update
October 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, China